Drug Type Hormone |
Synonyms |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | CN | 13 Oct 2020 | |
Diabetes Mellitus, Type 2 | Phase 3 | CN | 13 Oct 2020 | |
Diabetes Mellitus, Type 2 | Phase 3 | CN | 13 Oct 2020 | |
Short Bowel Syndrome | Phase 3 | US | Elgan Pharma Ltd.Startup | 20 Mar 2017 |
Short Bowel Syndrome | Phase 3 | US | 20 Mar 2017 |
Phase 2/3 | 2 | (NTRA-9620-A) | fmybatiqfu(ukguwtaayq) = zrdrehytrs exrnbbuuvd (zfusccvrkc, ladcajnwlu - igydpqnvwd) View more | - | 12 Oct 2021 | ||
(NTRA-9620-B) | fmybatiqfu(ukguwtaayq) = wgibzgkhba exrnbbuuvd (zfusccvrkc, xferridfxs - cxupiiivek) View more |